Orthopedics · Shoulder SurgeryTrial Updateclinicalmid-term

Study Compares Biceps Tenodesis Techniques in Patients Without Rotator Cuff Tears

Importance7/ 10

ActionMonitor

AutoResearch

Multi-agent research across ingested FDA, EMA, MHRA, PMDA, PubMed, ClinicalTrials.gov, company documents, and Humanexa signals.

Last run 7/13/2026, 6:03:22 AM

Assessment confidence: 76% · The main uncertainty is whether clinical benefit translates into regulatory momentum and guideline influence.

Executive Thesis

This trial addresses a significant gap in orthopedic surgical practices by comparing two biceps tenodesis techniques, which could lead to a shift in standard treatment protocols. The outcomes may influence product development and market dynamics for surgical devices in this therapeutic area. Regulatory context from FDA (List of Off-Patent, Off-Exclusivity Drugs without an Approved Generic) supports the near-term read. Assessment grounded in 21 ranked evidence items (15 high-relevance).

Strategic Assessment

If autobloc tenodesis proves superior, it could shift standard treatment protocols, impacting market dynamics for surgical techniques and devices. The strongest clinical anchor is Biceps Tenodesis With 360 Suture Anchor Versus Self Locking Tenodesis In the Absence of Rotator Cuff Tears (ClinicalTrials.gov), moderate corpus alignment. In Orthopedics · Shoulder Surgery, 5 regulatory and 4 competitive items passed relevance filtering for orthopedic device manufacturers.

Competitive Pressure

The most relevant competitive pressure comes from Pfizer's Ibuzatrelvir Study Targets High-Risk COVID-19 Patients (Humanexa Signals) — sponsor/company relevance (pfizer). Secondary pressure from U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility.

Regulatory Outlook

Regulatory risk is concentrated around List of Off-Patent, Off-Exclusivity Drugs without an Approved Generic (FDA). Regulatory pathway relevance (nda). The trial's outcomes are unlikely to directly affect regulatory approvals but may inform clinical guidelines that influence future product labeling.

Key Opportunities

If the autobloc tenodesis technique is proven superior, it could alter market share dynamics among orthopedic device manufacturers and impact revenue streams associated with surgical techniques.
If autobloc tenodesis proves superior, it could shift standard treatment protocols, impacting market dynamics for surgical techniques and devices.

What Would Change This Assessment

This becomes more urgent if Monitor outcomes of the trial and any subsequent changes in clinical guidelines or product offerings in biceps tenodesis.
Timeline shift beyond mid term would change urgency.
A competitor label expansion or pivotal readout in the same sub-indication would increase competitive pressure.

Supporting Evidence

List of Off-Patent, Off-Exclusivity Drugs without an Approved Generic
FDAhigh relevance
Regulatory pathway relevance (nda)
FDA document
View source
Condition-Specific Meeting Reports and Other Information Related to Patients' Experience
FDAhigh relevance
Moderate corpus alignment
FDA document
View source
FDA Alerts Health Care Providers to Cases of Neurologic Complications from General Anesthesia Linked to Genetic Variant in Patients of Maternal Venezuelan Ancestry
FDAhigh relevance
Moderate corpus alignment
FDA document
View source
FDA Approves New Treatment That Uses Donor Immune Cells to Prevent Serious Complications in Blood Cancer Patients
FDAhigh relevance
Moderate corpus alignment
FDA document
View source
FDA Approves New Indication for Tzield (teplizumab) for Certain Pediatric Patients with Recently Diagnosed Stage 3 Type 1 Diabetes
FDAhigh relevance
Moderate corpus alignment
FDA document
View source

Biceps Tenodesis With 360 Suture Anchor Versus Self Locking Tenodesis In the Absence of Rotator Cuff Tears
ClinicalTrials.govhigh relevance
Moderate corpus alignment
FDA document
View source
Comparative Evaluation of Sustained meChanical AsPiration Thrombectomy and no Thrombus Modification for Pre-stent Thrombus bUrden Reduction in Patients With Acute Myocardial Infarction Study: the CAPT
ClinicalTrials.govmedium relevance
Moderate corpus alignment
FDA document
View source
A Study of Gemcitabine/Nab-paclitaxel and Radiation Therapy Followed by Surgery in Patients With Advanced Pancreatic Cancer
ClinicalTrials.govmedium relevance
Moderate corpus alignment
FDA document
View source
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
ClinicalTrials.govmedium relevance
Moderate corpus alignment
FDA document
View source
OsseoFit Stemless Shoulder System (Anatomic)
ClinicalTrials.govmedium relevance
Moderate corpus alignment
FDA document
View source
A Safety, Tolerability and Levodopa Pharmacokinetics Study of Repeated ND0612 in Parkinson's Disease Patients
ClinicalTrials.govmedium relevance
Moderate corpus alignment
FDA document
View source

Pfizer's Ibuzatrelvir Study Targets High-Risk COVID-19 Patients
Humanexa Signalshigh relevance
Sponsor/company relevance (Pfizer)
U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility
Pfizerhigh relevance
Sponsor/company relevance (Pfizer)
FDA document
View source
Merck and Gilead Provide Update on Phase 3 KEYNOTE-D46/EVOKE-03 Study
Merckhigh relevance
Sponsor/company relevance (Merck)
FDA document
View source
Roche's ENSPRYNG shows 68% relapse reduction in Phase III MOGAD study
Humanexa Signalshigh relevance
Sponsor/company relevance (Roche)

Transdermal versus oral hormone replacement therapy and bone mass density in Turner syndrome patients: a pilot study.
PubMedhigh relevance
Moderate corpus alignment
FDA document
View source
Risk Factors, Cancer Types and Prognostic Significance of Second Primary Cancer After Early-, Intermediate- and Late-Onset Colorectal Cancer: A Retrospective Study in Chinese High-Volume Cancer Center
PubMedhigh relevance
Moderate corpus alignment
FDA document
View source
A qualitative study exploring discharge readiness experiences among patients with esophageal cancer undergoing esophagectomy.
PubMedhigh relevance
Moderate corpus alignment
FDA document
View source
Efficacy and tolerability of linezolid as an adjunctive treatment for nontuberculous mycobacterial infections in patients with adult-onset immunodeficiency syndrome: a prospective cohort study.
PubMedhigh relevance
Moderate corpus alignment
FDA document
View source
Clinical manifestations and ultrasonographic features of lobular endocervical glandular hyperplasia: a retrospective study of 135 patients.
PubMedhigh relevance
Moderate corpus alignment
FDA document
View source
Effects of intraoperative low-dose remimazolam maintenance on emergence agitation and emergence time in patients undergoing oral surgery: protocol for a randomized controlled trial.
PubMedmedium relevance
Moderate corpus alignment
FDA document
View source

Regunera

Precedents · guidance

Reg

Loading regulatory precedents…

View full regulatory analysis

Competitiva

Competitors · threats

Intel

Loading competitive findings…

View full competitive analysis

Why this matters

Affected entities

orthopedic device manufacturers

Commercial impact

medium

If the autobloc tenodesis technique is proven superior, it could alter market share dynamics among orthopedic device manufacturers and impact revenue streams associated with surgical techniques.

Regulatory impact

low

The trial's outcomes are unlikely to directly affect regulatory approvals but may inform clinical guidelines that influence future product labeling.

What to watch

Monitor outcomes of the trial and any subsequent changes in clinical guidelines or product offerings in biceps tenodesis.

Recommended action

Monitor

Track for follow-up milestones; no immediate action required.